Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients Ananworanich, Jintanat; Hill, Andrew; Siangphoe, Umaporn; Ruxrungtham, Kiat; ... Hirschel, Bernard 2005
add to browser selection
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Ananworanich, Jintanat; Gayet-Ageron, Angèle; Le Braz, Michelle; Prasithsirikul, Wisit; ... Hirschel, Bernard 2006
add to browser selection
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy Ananworanich, Jintanat; Nuesch, Reto; Côté, Hélène C. F.; Kerr, Stephen J.; ... Hirschel, Bernard 2008
add to browser selection
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial Ananworanich, Jintanat; Nuesch, Reto; Le Braz, Michelle; Chetchotisakd, Ploechan; ... Yerly Ferrillo, Sabine 2003
add to browser selection
Immunological recovery and antiretroviral therapy in HIV-1 infection Battegay, Manuel; Nuesch, Reto; Hirschel, Bernard; Kaufmann, G. R. 2006
add to browser selection
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection Nuesch, Reto; Ananworanich, Jintanat; Srasuebkul, Preeyaporn; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2008
add to browser selection
The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients Nuesch, Reto; Gayet-Ageron, Angèle; Chetchotisakd, Ploenchan; Prasithsirikul, Wisit; ... Ananworanich, Jintanat 2009
add to browser selection
Treatment interruption for convenience, cost cutting and toxicity sparing Nuesch, Reto; Hirschel, Bernard 2007